209.3: Treating iPSC-derived β Cells With Monoclonal Antibody Brentuximab Reduces the Risk of Teratoma Upon Transplantation. Issue 12 (24th November 2021)

Record Type:: Journal Article
Title:: 209.3: Treating iPSC-derived β Cells With Monoclonal Antibody Brentuximab Reduces the Risk of Teratoma Upon Transplantation. Issue 12 (24th November 2021)
Main Title:: 209.3: Treating iPSC-derived β Cells With Monoclonal Antibody Brentuximab Reduces the Risk of Teratoma Upon Transplantation
Authors:: Zamarian, Valentina
Pellegrini, Silvia
Landi, Elisa
Manenti, Fabio
Schiavolena, Marco
Citro, Antonio
Piemonti, Lorenzo
Sordi, Valeria
Abstract:
Is Part Of:: Transplantation. Volume 105:Issue 12S1 (2021)
Journal:: Transplantation
Issue:: Volume 105:Issue 12S1 (2021)
Issue Display:: Volume 105, Issue 12, Part S1 (2021)
Year:: 2021
Volume:: 105
Issue:: 12
Part:: S1
Issue Sort Value:: 2021-0105-0012-NaN
Page Start:: S14
Page End:: S14
Publication Date:: 2021-11-24
Subjects:: Transplantation of organs, tissues, etc -- Periodicals
Transplantation immunology -- Periodicals
617.95
Journal URLs:: http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/01.tp.0000804348.54160.6b ↗
Languages:: English
ISSNs:: 0041-1337
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 9024.990000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 25654.xml